loading
前日終値:
$45.04
開ける:
$45.26
24時間の取引高:
21,231
Relative Volume:
0.05
時価総額:
$2.62B
収益:
-
当期純損益:
$-118.49M
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
$-110.57M
1週間 パフォーマンス:
-13.85%
1か月 パフォーマンス:
-17.04%
6か月 パフォーマンス:
-10.71%
1年 パフォーマンス:
+150.24%
1日の値動き範囲:
Value
$43.66
$46.37
1週間の範囲:
Value
$43.66
$51.13
52週間の値動き範囲:
Value
$16.39
$72.29

Apogee Therapeutics Inc Stock (APGE) Company Profile

Name
名前
Apogee Therapeutics Inc
Name
セクター
Healthcare (1195)
Name
電話
650-394-5230
Name
住所
221 CRESCENT ST., WALTHAM
Name
職員
91
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
APGE's Discussions on Twitter

APGE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
APGE 43.91 2.62B 0 -118.49M -110.57M 0.00
VRTX 447.00 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.05 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 586.52 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.92 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.55 24.49B 3.30B -501.07M 1.03B 11.54

Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-10 開始されました BofA Securities Buy
2023-12-20 開始されました BTIG Research Buy
2023-08-08 開始されました Guggenheim Buy
2023-08-08 開始されました Jefferies Buy
2023-08-08 開始されました Stifel Buy
2023-08-08 開始されました TD Cowen Outperform
2023-08-08 開始されました Wedbush Outperform
すべてを表示

Apogee Therapeutics Inc (APGE) 最新ニュース

pulisher
Nov 19, 2024

Victory Capital Management Inc. Grows Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024 - The Manila Times

Nov 18, 2024
pulisher
Nov 18, 2024

Apogee Therapeutics Unveils First R&D Day: Spotlight on APG777 and Immunology Pipeline | APGE Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

Wedbush Cuts Earnings Estimates for Apogee Therapeutics - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Driehaus Capital Management LLC Acquires Shares in Apogee Therap - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Stifel maintains Buy on Apogee Therapeutics with $95 target By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 13, 2024

Stifel maintains Buy on Apogee Therapeutics with $95 target - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

FMR LLC Adjusts Stake in Apogee Therapeutics Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Apogee Therapeutics Highlights Pipeline Progress and Financials - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

APGEApogee Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024
pulisher
Nov 10, 2024

Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis - Seeking Alpha

Nov 10, 2024
pulisher
Nov 09, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Insider Carl Dambkowski Sells 6,665 Shares - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Michael Thomas Henderson Sells 15,000 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) Stock - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Apogee Therapeutics Inc (APGE) Worth Considering For The Next Few Weeks - Stocks Register

Nov 09, 2024
pulisher
Nov 08, 2024

Insider Sale at Apogee Therapeutics Inc (APGE): Chief Medical Of - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Apogee Therapeutics chief medical officer sells shares worth $394,041 - Investing.com India

Nov 08, 2024
pulisher
Nov 08, 2024

Apogee Therapeutics CEO sells shares worth $888,320 - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Apogee Therapeutics chief medical officer sells shares worth $394,041 By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 06, 2024

(APGE) Proactive Strategies - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 06, 2024

Apogee Therapeutics (NASDAQ:APGE) and Fennec Pharmaceuticals (NASDAQ:FENC) Financial Contrast - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World

Nov 05, 2024
pulisher
Nov 04, 2024

Apogee Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewswire

Nov 04, 2024
pulisher
Oct 31, 2024

Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive

Oct 31, 2024
pulisher
Oct 31, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 31, 2024
pulisher
Oct 27, 2024

(APGE) Investment Analysis and Advice - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 25, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Wedbush Reiterates Outperform Rating for Apogee Therapeutics (NASDAQ:APGE) - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Apogee Therapeutics Unveils Promising Phase 1 Trial Results - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

Apogee Therapeutics Announces Results Up to 9 Months from - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel - The Bakersfield Californian

Oct 24, 2024
pulisher
Oct 24, 2024

Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases - StockTitan

Oct 24, 2024
pulisher
Oct 20, 2024

Waypoint Capital Advisors LLC Invests $36.84 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Oct 20, 2024
pulisher
Oct 18, 2024

Apogee Therapeutics (NASDAQ:APGE) Trading Down 4.1%Here's What Happened - MarketBeat

Oct 18, 2024
pulisher
Oct 16, 2024

(APGE) Technical Pivots with Risk Controls - Stock Traders Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting - GlobeNewswire

Oct 16, 2024
pulisher
Oct 16, 2024

11,535 Shares in Apogee Therapeutics, Inc. (NASDAQ:APGE) Acquired by AQR Capital Management LLC - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Short Interest Down 11.7% in September - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Millennium Management LLC Lowers Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Oct 14, 2024
pulisher
Oct 09, 2024

Apogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Analyzing Apogee Therapeutics Inc. (APGE) After Recent Trading Activity - Knox Daily

Oct 08, 2024
pulisher
Oct 08, 2024

Ratio Examination: Apogee Therapeutics Inc. (APGE)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Oct 08, 2024
pulisher
Oct 07, 2024

Apogee Therapeutics, Inc. (APGE): A Hot Stock to Buy Now - Insider Monkey

Oct 07, 2024
pulisher
Oct 05, 2024

Squarepoint Ops LLC Purchases 25,829 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat

Oct 05, 2024
pulisher
Oct 05, 2024

Apogee Therapeutics Inc CEO Michael Henderson Sells 40,000 Shares - GuruFocus.com

Oct 05, 2024
pulisher
Oct 04, 2024

Carl Dambkowski Sells 6,665 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) Stock - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Apogee Therapeutics CEO sells over $2.2 million in company stock By Investing.com - Investing.com Canada

Oct 04, 2024

Apogee Therapeutics Inc (APGE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):